疾病标记

PDF
疾病标记/2006/文章
特殊的问题

神经系统的疾病标志物

浏览特刊

开放获取

体积 22 |文章的ID 276239 | https://doi.org/10.1155/2006/276239

向仲民,Vahram Haroutunian, Lap Ho, Dushant Purohit, Giulio Maria Pasinetti 小胶质细胞在大脑中的激活作为阿尔茨海默病神经病理学和临床痴呆的炎症生物标志物",疾病标记 卷。22 文章的ID276239 8 页面 2006 https://doi.org/10.1155/2006/276239

小胶质细胞在大脑中的激活作为阿尔茨海默病神经病理学和临床痴呆的炎症生物标志物

收到了 2005年11月11日
接受 2005年11月11日

摘要

小胶质细胞介导的炎症在阿尔茨海默病(AD)神经病理学进展中的作用尚不清楚。在这项研究中,后期大脑部分来自广告和控制情况下受到人类白细胞抗原(HLA)是免疫组织化学检查小胶质细胞激活广告评估的进展pre-mortem临床痴呆评定(CDR)和尸检病理表现神经炎的斑块(NP)和神经原纤维缠结(NT)根据Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). In both gray and white matter of the entorhinal cortex (EC) and HLA-DR immunostaining increased with the progression of CDR or CERAD NP, and to a lesser degree with CERAD NT. Between CDR stages HLA-DR significance was found in moderate (CDR 2) to severe dementia (CDR 5) where as between CERAD NP stages staining increased significantly from NP 0 (no plaque) to NP 1 (sparse plaques), suggesting increased microglia activation begins with amyloid NP deposition. In the hippocampus, a significant increase in microglia immunostaining was found in the pyramidal cell layer of CA1 as early as CDR 1, and in the upper molecular layer of the dentate gyrus in CDR 0.5. This increase continues with the progression of CDR and reaches maximum in CDR 5. When assessed by CERAD NP stages however, a significant increase in microglia immunostaining was found only in mid-to-late stages (NP 3) and reduced staining was seen in NP 5. These results suggest that microglia activation increases with the progression of AD, with the increase varying depending on the involved brain region.

版权所有©2006 Hindawi出版公司。这是一篇发布在知识共享署名许可协议,允许在任何媒介上不受限制地使用、传播和复制,但必须正确引用原作。


更多相关文章

PDF 下载引用 引用
订单打印副本订单
的观点281
下载627
引用

年度文章奖:由主编评选的2020年杰出研究贡献。阅读获奖文章